JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Activity Details

130 * Mon, 8/1/2011, 8:30 AM - 10:20 AM CC-D237
Issues with Adaptive Designs and DMCS — Contributed Papers
Biopharmaceutical Section
Chair(s): Kyoungah See, Eli Lilly and Company
8:35 AM Sample Size Reassessment in Fixed-Duration Survival Trials Alison Pedley, Boston University ; Ralph B. D'Agostino Sr., Boston University ; Michael Pencina, Boston University ; Joseph Massaro, Boston University
8:50 AM A Bayesian Adaptive Dropping-Arm Design Using Multiple Interim Evaluations for Decisionmaking Yili L. Pritchett, Abbott Laboratories ; Shihua Wen, Abbott Laboratories
9:05 AM Simulation and Optimization of an Adaptive Phase II Dose-Finding Study Yannis Jemiai, Cytel Inc.
9:20 AM Futility Rule and Unblind Sample Size Re-Estimation in Phase III Drug Development: Method and Practical Example Kyoungah See, Eli Lilly and Company
10:15 AM Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.